Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
Riyadh Air Expands Fleet with Airbus and Boeing Orders
Riyadh Air's 34-jet expansion lifts Airbus' near-term backlog, while Boeing's 28 orders, mostly pending, hold larger long-term revenue potential.
SK hynix ADR Premium Widens to 29% Amid Seoul Selloff
SK hynix shares fell 4.23% in Seoul, widening the ADR premium to 29% as U.S. demand diverges from domestic price discovery.
Apple Narrows Nvidia's Market Cap Lead by Nearly $470 Billion in a Week
Apple has slashed Nvidia's market-cap lead by roughly $470 billion in five trading sessions, driven by Apple's 5.84% gain and Nvidia's 3.86% decline.
Sadot Group Soars 78% on Filing Hinting at 61 Million Share Reserve
Sadot Group shares jumped 77.5% on Friday after a regulatory filing indicated a reserve of 61.3 million shares for potential note conversion, far exceeding outstanding shares.
Ondas Shares Drop 10% as DZYNE Stock Delivery Looms
Ondas shares slid 10.1% last week to $6.53, as the market eyes a 45 million-share DZYNE delivery in January that will expand the share count by 7.9%.
Alibaba Shares Jump 3.7% on Qwen3.8 Model, AI Uplift Still Contained
Alibaba (HKG:9988) shares gained 3.73% on Monday following the unveiling of its Qwen3.8 AI model, though the stock's AI premium remained subdued amid broader tech gains.
Shell Gains Only 41% of Brent Rally as Gulf Risks Cap Gains
Shell shares gained 6.5% last week, but that was only 41% of Brent's 15.9% climb. Gulf region exposure and cash conversion challenges are in focus ahead of Q2 results.
EOS Shares Recover, Still Lag Below May Placement Price
EOS shares edged up 1.6% to A$7.14, still 10.8% under the A$8 May placement price. A A$726M backlog, about 46% of market cap, provides support but profit conversion remains uncertain.
Telix Pharma Slides 8.4% in Five Days, Japan Opportunity Excluded from 2026 Guidance
Telix Pharmaceuticals (ASX:TLX) shares fell 8.4% in five sessions, trailing the ASX 200 by 8.3 points. Enrollment in Japan Phase 3 reached 105 patients, but Japan remains outside 2026 revenue guidance.
Tetratherix Maintains A$358M Valuation Amid Thin Trading
Tetratherix (ASX:TTX) holds a A$358 million valuation as only 55.6% of shares trade freely. A large escrow block restricts supply, amplifying price swings.